Author

Claudia Pisanu

Department of Biomedical Sciences, University of Cagliari - Cited by 2,169 - bipolar disorder - biostatistics - pharmacogenomics

Biography

Dr Claudia is Resident Intern in Medical Pharmacology, University of Cagliari · Department of Biomedical Sciences Italy · Cagliari from Jul 2012 till present . She has a vast Teaching Experience as Lecturer from ep 2014 Azienda Sanitaria Locale Cagliari, Italy · Cagliari. She has completed her Degree in medicine and surgery in year Sep 2005–Oct 2011 from University of Cagliari. She has  got many Awards & achievements in years 2010.2013,2014 and 2015. Her area of research is Pharmacogenomics, Personalized Medicine, Bipolar Disorder,  Genetic Association, Genetic Association Studies  
Title
Cited by
Year
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...Nature genetics 54 (4), 412-436, 2022202
420
2022
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...Nature communications 12 (1), 3417, 2021202
119
2021
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics
M Manchia, A Fontana, C Panebianco, P Paribello, C Arzedi, E Cossu, ...Biomedicines 9 (8), 875, 2021202
22
2021
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
O Affatato, TC Moulin, C Pisanu, VS Babasieva, M Russo, EI Aydinlar, ...Journal of translational medicine , 1-11, 2021202
19
2021
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications
A Squassina, M Manchia, C Pisanu, R Ardau, C Arzedi, A Bocchetta, ...Neuropsychopharmacology 45 (13), 2229-2238, 2020202
18
2020
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
KO Schubert, A Thalamuthu, AT Amare, J Frank, F Streit, M Adl, N Akula, ...Translational psychiatry 11 (1), 606, 2021202
18
2021
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder
A Nunes, W Stone, R Ardau, A Berghöfer, A Bocchetta, C Chillotti, ...Translational Psychiatry 11 (1), 36, 2021202
14
2021
Characterisation of age and polarity at onset in bipolar disorder
JL Kalman, LMO Loohuis, A Vreeker, A McQuillin, EA Stahl, D Ruderfer, ...The British Journal of Psychiatry 219 (6), 659-669, 2021202
13
2021
Presenting psychiatric and neurological symptoms and signs of brain tumors before diagnosis: a systematic review
F Ghandour, A Squassina, R Karaky, M Diab-Assaf, P Fadda, C PisanuBrain Sciences 11 (3), 301, 2021202
10
2021
Prediction of lithium response using genomic data
W Stone, A Nunes, K Akiyama, N Akula, R Ardau, JM Aubry, L Backlund, ...Scientific reports 11 (1), 1155, 2021202
9
2021
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study
NZ Welander, G Olivo, C Pisanu, G Rukh, HB Schiöth, J MwinyiBrain and behavior 11 (8), e221, 2021202
9
2021
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach
M Cearns, AT Amare, KO Schubert, A Thalamuthu, J Frank, F Streit, M Adli, ...The British Journal of Psychiatry 220 (4), 219-228, 2022202
7
2022
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders
S Le Clerc, L Lombardi, BT Baune, AT Amare, KO Schubert, L Hou, ...Scientific reports 11 (1), 1823, 2021202
7
2021
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review
C Pisanu, G Severino, I De Toma, M Dierssen, P Fusar-Poli, M Gennarelli, ...European Neuropsychopharmacology , 112-17, 2022202
5
2022
Is poor lithium response in individuals with bipolar disorder associated with increased degradation of tryptophan along the kynurenine pathway? Results of an exploratory study
FT Fellendorf, M Manchia, A Squassina, C Pisanu, S Dall’Acqua, S Sut, ...Journal of Clinical Medicine 11 (9), 2517, 2022202
4
2022
Multi-omics data integration methods and their applications in psychiatric disorders
A Sathyanarayanan, TT Mueller, MA Moni, K Schueler, BT Baune, P Lio, ...European Neuropsychopharmacology 69, 26-6, 2023202
4
2023
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank
C Pisanu, NZ Welander, G Rukh, HB Schiöth, J MwinyiBiomedicine & Pharmacotherapy 13, 11223, 2021202
4
2021
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy
C Pisanu, E Vitali, A Meloni, D Congiu, G Severino, R Ardau, C Chillotti, ...Journal of Personalized Medicine 11 (11), 1100, 2021202
3
2021
Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an …
A Carta, M Del Zompo, A Meloni, F Mola, P Paribello, F Pinna, M Pinna, ...Clinical Drug Investigation 42 (9), 7-746, 2022202
3
2022
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
M Manchia, U Isayeva, R Collu, D Primavera, L Deriu, E Caboni, ...Brain Sciences 12 (12), 1666, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=n-Owr0IAAAAJ&hl=en

Cited by
Citations 2169
h-index 23
i10-index 50
Recommended Journals
Open Access Journals